• $153,587.00
    Market Cap
  • -98.95%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
09/30/2025
09/30/2024
09/30/2023
09/30/2022
Income Statement
Total Operating Revenue
17,733
+2,248.74%
755
-99.40%
126,560
+0.83%
125,517
+105.11%
Cost of Revenue
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Gross Profit
17,733
+2,248.74%
755
-99.40%
126,560
+0.83%
125,517
+105.11%
Sales and Marketing Expense
0
N/A
0
N/A
0
N/A
0
N/A
Research and Development Expense
-11,725
N/A
N/A
N/A
-212,297
+34.25%
-158,138
+330.85%
Depreciation and Amortization Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Operating Expenses
575,101
-12.03%
653,781
-29.21%
923,509
+60.58%
575,122
+54.62%
Operating Profit
-1.3M
+205.47%
-417,221
-39.26%
-686,950
+102.28%
-339,605
+69.15%
Interest Income
N/A
N/A
N/A
N/A
0
N/A
N/A
N/A
Interest Expense
N/A
N/A
N/A
N/A
-58,584
-57.77%
-138,720
-56.10%
Interest Income and Expense and Net
0
N/A
0
+100.00%
-58,584
-57.77%
-138,720
-56.10%
Total Nonoperating Income and Expense
N/A
N/A
N/A
N/A
1.8M
+405,055.16%
455
+97.83%
Income before Taxes
-1.3M
+90.72%
-668,255
-165.29%
1.0M
-54.04%
2.2M
+132.92%
Income Taxes
0
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
-1.3M
+90.72%
-668,255
-157.78%
1.2M
-52.67%
2.4M
+136.12%
Net Income from Continuing Operations Applicable to Common
-1.3M
+90.72%
-668,255
-165.29%
1.0M
-54.04%
2.2M
+132.92%
Basic EPS and Net Income
-0.05
-68.75%
-0.16
-155.17%
0.29
N/A
N/A
N/A
Diluted EPS and Net Income
-0.05
-68.75%
-0.16
-155.17%
0.29
N/A
N/A
N/A
Basic Weighted Average Shares
23.5M
+472.27%
4.1M
+16.21%
3.5M
-99.92%
4.7B
+56.19%
Diluted Weighted Average Shares
23.5M
+472.27%
4.1M
+16.21%
3.5M
-99.92%
4.7B
+56.19%
Balance Sheet
Cash and Cash Equivalents
69,555
+9,614.39%
716
-99.41%
121,037
+136.38%
51,204
-92.96%
Short-Term Investments
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
69,555
+9,614.39%
716
-99.41%
121,037
+136.38%
51,204
-92.96%
Total Current Assets
274,628
+91.58%
143,351
+9.40%
131,037
-61.05%
336,422
-66.16%
Accumulated Depreciation
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Property and Plant and Equipment and Net
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Long-Term Assets
N/A
N/A
N/A
N/A
222,580
0.00%
222,580
+2.11%
Total Assets
274,628
+70.49%
161,084
-54.45%
353,617
-36.74%
559,002
-53.88%
Income Taxes Payable
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Short-Term Debt
1.4M
0.00%
1.4M
+1,404.18%
95,710
-95.73%
2.2M
+3.14%
Total Current Liabilities
6.6M
+21.89%
5.4M
+1.33%
5.3M
-38.24%
8.6M
-41.52%
Total Long-Term Debt
1.2M
+244.72%
350,000
-46.11%
649,494
-48.58%
1.3M
-64.53%
Total Long-Term Liabilities
2.1M
+48.11%
1.4M
+838.48%
149,614
-95.79%
3.6M
-57.31%
Total Liabilities
6.6M
+21.89%
5.4M
-1.45%
5.5M
-36.50%
8.6M
-41.52%
Retained Earnings
-21.7M
+6.24%
-20.4M
+3.38%
-19.7M
-5.53%
-20.9M
-10.47%
Total Stockholders Equity
-6.3M
N/A
N/A
N/A
-5.1M
-36.49%
-8.0M
-40.41%
Total Shares Outstanding
39.4M
+648.82%
5.3M
+49.96%
3.5M
-99.93%
5.0B
+15.65%
Cash Flow
Cash from Operating Activities
-383,591
-48.96%
-751,536
+332.12%
-173,917
-128.66%
606,921
+153.67%
Capital Expenditures
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Investing Activities
N/A
N/A
N/A
N/A
25,000
0.00%
25,000
-94.95%
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
452,430
-28.32%
631,215
+158.96%
243,750
+359.21%
-94,036
-106.90%
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Operating Margin
-7,187.18%
-86.99%
-55,261.06%
+10,081.00%
-542.79%
+100.61%
-270.56%
-17.53%
Return on Assets
-585.02%
+125.30%
-259.67%
-202.45%
253.45%
-8.15%
275.93%
+127.23%
Return on Equity
N/A
N/A
N/A
N/A
-17.60%
-22.48%
-22.71%
-134.94%
Revenue Growth
2,248.74%
+2,362.24%
-99.40%
-12,061.90%
0.83%
-99.21%
105.11%
+336.91%
Current Ratio
0.04
+56.93%
0.03
+8.10%
0.02
-36.83%
0.04
-42.16%
Cash Ratio
0.01
+10,500.00%
0.0001
-99.56%
0.02
+280.00%
0.006
-87.88%
Debt-to-Equity Ratio
-0.42
N/A
N/A
N/A
-0.15
-66.50%
-0.44
+2.54%
Debt-to-Assets Ratio
9.64
-13.27%
11.11
+427.19%
2.11
-66.36%
6.26
+32.49%

Earnings & Revenue History

Debt-to-Assets

Cash Flow